Metabolic syndrome: a comprehensive review

Authors

  • Ramachandra Bhat C. Institute of Pharmacology, Madras Medical College, Chennai, Tamil Nadu, India
  • Santhosh T. Institute of Pharmacology, Madras Medical College, Chennai, Tamil Nadu, India
  • Sudha K. M. Institute of Pharmacology, Madras Medical College, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20233913

Keywords:

Metabolic syndrome, Hypertension, Diabetes, Hyperlipidaemia, Insulin resistance, Hyperglycaemia, Hyperinsulinemia, Kidney stones

Abstract

Metabolic syndrome (syndrome X) includes several components like diabetes, hypertension, hyperlipidemia etc. Every patient should undergo detailed assessment for the silent presence of the components of metabolic syndrome. Genetic predisposition, increased nutrient- dense food, decreased physical activity and chronic stress are common in metabolic syndrome. Insulin resistance, obesity and hyperglycaemia are commonly seen which can later lead to serious consequences like cardiovascular complications, thrombotic events etc. Clinical features depend on the components of the metabolic syndrome in a patient. Some may present with complications and advanced disease. For non-diabetic individuals, oral glucose tolerance test is indicated. It is better to study serum uric acid level and to screen for silent kidney stones. Specific drugs are prescribed as indicated. Drugs for stress and insomnia are also prescribed. Thrombotic status of the patient should be considered, and antiplatelet drugs are prescribed if risk factors are present. Non-pharmacological measures like diet modification and increased physical activity should be given on a priority basis. Patient compliance of these two measures should be monitored regularly. Future deployment of “artificial intelligence – powered” predictive diagnostic tests will help in detecting and controlling metabolic syndrome. “At risk” individuals and patients showing some components of metabolic syndrome should undergo full investigations to detect other components of metabolic syndrome. Full range of therapeutic drugs, diet modification and increased physical activity should be prescribed.

References

Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. 2004;59:207-23.

Metabolic syndrome. Available at: https://en.wiki pedia.org/w/index.php?title=Metabolic_syndrome&oldid=1174758966. Accessed on 20 August 2023.

Saboya PP, Bodanese LC, Zimmermann PR, Gustavo AD, Assumpção CM, Londero F. Metabolic syndrome and quality of life: a systematic review. Rev Lat Am Enfermagem. 2016;24:e2848.

Zaman SG. Pathogenesis of insulin resistance, Cellular Metabolism and Related Disorders. Intechopen. 2020.

Ahmadinezhad M, Arshadi M, Hesari E, Sharafoddin M, Azizi H, Khodamoradi F. The relationship between metabolic syndrome and its components with bladder cancer: a systematic review and meta-analysis of cohort studies. Epidemiol Health. 2022;44:e2022.

Wondmkun YT. Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications. Diabetes Metab Syndr Obes. 2020;13:3611-6.

Ighbariya A, Weiss R. Insulin Resistance, Prediabetes, Metabolic Syndrome: What Should Every Pediatrician Know? J Clin Res Pediatr Endocrinol. 2017;9(2):49-57.

Lee SH, Park SY, Choi CS. Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes Metab J. 2022;46(1):15-37.

Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018;98(4):2133-223.

Iftikhar IH, Donley MA, Mindel J, Pleister A, Soriano S, Magalang UJ. Sleep Duration and Metabolic Syndrome. An Updated Dose-Risk Metaanalysis. Ann Am Thorac Soc. 2015;12(9):1364-72.

Martins LM. Type B insulin resistance syndrome: A systematic review. Arch Endocrinol Metab. 2011;12:32-9.

Daudt LD, Musskopf ML, Mendez M, Remonti LLR, Leitão CB, Gross JL, et al. Association between metabolic syndrome and periodontitis: a systematic review and meta-analysis. Braz Oral Res. 2018;32:e35.

Dai X. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. Eur J Epidemiol. 2013;28(8):669-76.

Johnson RJ, Perez-Pozo SE, Lillo JL, Grases F, Schold JD, Kuwabara M, et al. Fructose increases risk for kidney stones: potential role in metabolic syndrome and heat stress. BMC Nephrol. 2018;19(1):315.

Alshammary AF, Alharbi KK, Alshehri NJ, Vennu V, Ali Khan I. Metabolic Syndrome and Coronary Artery Disease Risk: A Meta-Analysis of Observational Studies. Int J Environ Res Public Health. 2021;18(4):1773.

Batista-Jorge GC, Barcala-Jorge AS, Silveira MF, Lelis DF, Andrade JMO, de Paula AMB, et al. Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program. Life Sci. 2020;256:117.

Sáez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil A. Effects of Probiotics and Synbiotics on Obesity, Insulin Resistance Syndrome, Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease: A Review of Human Clinical Trials. Int J Mol Sci. 2016;17(6):928.

Sooriyaarachchi P, Jayawardena R, Pavey T, King NA. Shift work and the risk for metabolic syndrome among healthcare workers: A systematic review and meta-analysis. Obes Rev. 2022;23(10):e13489.

Marcos-Delgado A, Hernández-Segura N, Fernández-Villa T, Molina AJ, Martín V. The effect of lifestyle intervention on health-related quality of life in adults with metabolic syndrome: a meta-analysis. Int J Environ Res Public Health. 2021;18(3):887.

Clifton P. Metabolic Syndrome-Role of Dietary Fat Type and Quantity. Nutrients. 2019;11(7):1438.

Downloads

Published

2023-12-26

How to Cite

C., R. B., T., S., & K. M., S. (2023). Metabolic syndrome: a comprehensive review. International Journal of Basic & Clinical Pharmacology, 13(1), 181–183. https://doi.org/10.18203/2319-2003.ijbcp20233913

Issue

Section

Review Articles